D. Feng

发表

On the Role of Substance P, Galanin, Vasoactive Intestinal Peptide, and Calcitonin Gene—related Peptide in Mediation of Spinal Reflex Excitability in Rats with Intact and Sectioned Peripheral Nerves a

K. Kristensson, Z. Wiesenfeld‐Hallin, J. Fahrenkrug, 1991, Annals of the New York Academy of Sciences.

Low-dose intrathecal morphine facilitates the spinal flexor reflex by releasing different neuropeptides in rats with intact and sectioned peripheral nerves

Z. Wiesenfeld‐Hallin, X. J. Xu, R. Håkanson, 1991, Brain Research.

Plasticity of the peptidergic mediation of spinal reflex facilitation after peripheral nerve section in the rat

Z. Wiesenfeld‐Hallin, X. J. Xu, R. Håkanson, 1990, Neuroscience Letters.

PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites.

V. Garsky, J. Lin, A. Oliff, 2001, Drug metabolism and disposition: the biological fate of chemicals.

Species Variability in Platelet and other Cellular Responsiveness to Thrombin Receptor-derived Peptides

R. Nutt, R. Gould, R. Gould, 1994, Thrombosis and Haemostasis.

A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity.

M. Bock, R. M. Dipardo, D. Reiss, 2008, Bioorganic & medicinal chemistry letters.

Studies on enzymic peptide synthesis: I. Synthesis of tryptophane analogue of Leu-enkephalin†

Jie Xu, D. Feng, Yu Wang, 1985 .

A prostate-specific antigen (PSA)-activated vinblastine prodrug selectively kills PSA-secreting cells in vivo.

R. Freidinger, Jiunn H. Lin, V. Garsky, 2002, Molecular cancer therapeutics.

Pharmacological assessment of spantide II analogues.

R. Håkanson, G. Strichartz, K. Folkers, 1994, European journal of pharmacology.

Spantide II, a novel tachykinin antagonist having high potency and low histamine-releasing effect

R. Håkanson, K. Folkers, S. Leander, 1990, Regulatory Peptides.

The specific antagonistic effect of intrathecal spantide II on substance P- and C-fiber conditioning stimulation-induced facilitation of the nociceptive flexor reflex in rat

Z. Wiesenfeld‐Hallin, X. J. Xu, K. Folkers, 1990, Brain Research.

Antinociceptive and substance P antagonistic effects of intrathecally injected spantide II in rat: no signs of motor impairment or neurotoxicity

K. Kristensson, Z. Wiesenfeld‐Hallin, R. Håkanson, 1990, Regulatory Peptides.

The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy.

R. Freidinger, V. Garsky, P. Lumma, 2001, Journal of medicinal chemistry.

Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 position.

M. Bock, R. Freidinger, J. Vacca, 1997, Journal of medicinal chemistry.

Tachykinins mediate changes in spinal reflexes after activation of unmyelinated muscle afferents in the rat.

Z. Wiesenfeld‐Hallin, X. J. Xu, R. Håkanson, 1991, Acta physiologica Scandinavica.

Intranigral substance P stimulation of striatal dopamine release is inhibited by Spantide II: a new tachykinin antagonist without apparent neurotoxicity

T. Hökfelt, U. Ungerstedt, M. Herrera-Marschitz, 1990, Brain Research.

Spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity.

R. Håkanson, K. Folkers, S. Leander, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Spantide III, a superior tachykinin antagonist with high potency and negligible neurotoxicity

A. Janecka, R. Håkanson, K. Folkers, 1993, Amino Acids.

Activity of spantide I and II at various tachykinin receptors and NK-2 tachykinin receptor subtypes.

C. Maggi, K. Folkers, R. Patacchini, 1991, European journal of pharmacology.

C. Bowers, K. Folkers, W. Hook, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Design, synthesis and bioassays of antagonists of LHRH which have high antiovulatory activity and release negligible histamine.

T. Okamoto, C. Bowers, K. Folkers, 1987, Biochemical and biophysical research communications.

Antagonists of LHRH superior to antide ; effective sequence/activity relationships

C. Bowers, K. Folkers, W. Hook, 1990 .

Design, Synthesis and Biological Evaluation of Antagonists of LHRH by Criteria of Potency, Safety and Solubility

C. Bowers, K. Folkers, W. Hook, 1991 .

An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey.

R. Nutt, J. Shafer, R. Gould, 1995, Circulation.

2,3-diaminopyridine bradykinin B1 receptor antagonists.

M. Bock, R. Freidinger, R. Chang, 2004, Journal of medicinal chemistry.

2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists.

Dong-Mei Feng, Cuyue Tang, Christina Ng, 2005, Bioorganic & medicinal chemistry letters.

Luteimonas cucumeris sp. nov., isolated a from cucumber leaf.

Hui Zhang, Zhanyong Sun, D. Feng, 2012, International journal of systematic and evolutionary microbiology.

Specificity of Design to Achieve Antagonists of LHRH of Increasing Effectiveness in Therapeutic Activity

C. Bowers, K. Folkers, D. Feng, 1987 .

A peptide–doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo

R. Freidinger, V. Garsky, P. Lumma, 2000, Nature Medicine.

Development of a potent thrombin receptor ligand.

D. Veber, R. Nutt, M. Tang, 1995, Journal of medicinal chemistry.

Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugates.

M. Bock, T. Baillie, S. Kuduk, 2005, Chemical research in toxicology.

Design and Synthesis of a Selective PSA Cleavable Peptide-Doxorubicin Prodrug Which Targets PSA Positive Tumor Cells

R. Freidinger, V. Garsky, P. Lumma, 2001 .